To further determine the cardioprotective components in the ASC-CM, they reported that trophic factors, including VEGF, HGF, MCP-1, TIMP-1, and TIMP-4, were beneficial for reducing scar fibrosis and inhibiting cardiac hypertrophy and remodeling for MI therapy [46]. The gene discussed is VEGFA; the disease is myocardial infarction.